Biopharma shares shake off the pandemic
Global drug stocks enthusiastically joined the recovery on the financial markets in the second quarter, more than offsetting earlier declines.
Forecasts tell a tale of two continents for biosimilars
Despite government rhetoric, the US biosimilar market has failed to live up to expectations so far.
